PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

↓ Download CSV

CIK 0001299130 · Nasdaq · Laboratory Analytical Instruments

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. reported revenue of $160.00M, up 3.9% from the prior year. The company ran a net loss, with a net margin of -341.5% and a gross margin of 28.6%. It held $784.08M in total assets against $778.73M in total liabilities.

Key ratios (FY2025)

28.6%
Gross margin
-346.2%
Operating margin
-341.5%
Net margin
-10214.5%
Return on equity
+3.9%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$160.00M$154.01M$200.52M$128.30M$130.51M$78.89M$90.89M$78.63M$93.47M$90.71M
Cost of Revenue$114.22M$116.73M$147.74M$79.27M$71.65M$46.33M$56.31M$58.81M$46.55M
Gross Profit$45.78M$37.28M$52.78M$49.03M$58.86M$32.57M$34.58M$25.10M$34.66M$44.16M
Operating Income-$553.86M-$474.31M-$334.47M-$307.20M-$210.44M-$104.39M-$100.55M-$100.99M-$89.78M-$71.24M
Net Income-$546.38M-$309.85M-$306.74M-$314.25M-$181.22M$29.40M-$84.13M-$102.56M-$92.19M-$74.38M
EPS (Diluted)$-1.82$-1.59$-1.21$-1.40$-0.89$0.17$-0.55$-0.76
Total Assets$784.08M$1.26B$1.75B$1.77B$2.01B$413.98M$147.99M$170.28M$144.08M$137.88M
Total Liabilities$778.73M$753.85M$1.04B$1.20B$1.22B$78.49M$93.07M$56.21M$57.98M$53.22M
Shareholders' Equity$5.35M$506.59M$701.30M$562.90M$790.99M$335.49M$54.92M$114.06M$86.10M$84.67M
Cash & Equivalents$63.71M$55.37M$179.91M$325.09M$460.73M$81.61M$29.63M$18.84M$16.51M$16.77M
Operating Cash Flow-$111.21M-$206.06M-$259.17M-$263.21M-$111.18M$19.50M-$78.31M-$66.43M-$67.52M-$67.93M
Capital Expenditures$2.71M$6.19M$8.84M$16.75M$5.93M$1.04M$2.84M$1.85M$10.43M$8.21M
Shares Outstanding301.96M294.42M267.74M226.50M220.98M192.29M153.12M150.24M116.28M92.68M
Dividends Per Share$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00